Health Sciences 2 (HSAQ) to Combine with Orchestra BioMed in $158M Deal

Health Sciences 2 (NASDAQ:HSAQ) has entered into a definitive agreement to combine with Orchestra BioMed at a pro forma fully diluted enterprise value of $158 million. New Hope, Pennsylvania-based Orchestra BioMed develops evidence-based therapeutic solutions for medical procedures that address major medical conditions, with a particular focus on cardiovascular diseases. The combined company is expected to trade on
Read More